调节T细胞中的p300-依赖调节在过敏喘中起着至关重要的作用
Eun Gyul Kim1, Mi Na Kim1, Soo-Yeon Park2
1Yonsei University College of Medicine, Pediatrics, Seoul, Korea (the Republic of).
American journal of respiratory and critical care medicine
|October 6, 2025
概括
E1A结合蛋白p300 (p300) 增强调节性T细胞 (Treg) 功能,防止过敏性喘. 在Tregs中,p300调节酸结合蛋白5 (GBP5),抑制呼吸道炎症.
科学领域:
- 免疫学 免疫学 免疫学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 呼吸系统医学 呼吸系统医学
背景情况:
- 喘是一种由表观遗传变化影响的慢性炎症性呼吸道疾病.
- E1A结合蛋白p300 (p300) 是一个关键的基因素乙转移酶,调节基因转录.
研究的目的:
- 研究p300在过敏性喘期间免疫反应中的作用.
- 了解p300调节T辅助2细胞和调节性T细胞 (Tregs) 的机制.
主要方法:
- 在小鼠中建立了过敏原诱导的喘模型,该模型具有系统和Treg特定的p300删除.
- 在小鼠和人类喘样本中评估了基因组乙转移酶活性和p300表达.
- 利用染色体免疫沉和RNA测序来识别Tregs中的p300点.
- 通过体外研究证实了酸结合蛋白5 (GBP5) 在Tregs中的功能.
主要成果:
- 在喘模型和患者中,p300水平和素乙转移酶活性升高.
- p300删除损害了Treg功能,并加剧了过敏性炎症.
- 染色体免疫沉和RNA测序确定了GBP5作为Tregs.中的p300点基因.
- GBP5过度表达部分恢复了Treg增殖,p300枯竭抑制了Treg增殖.
结论:
- 通过促进Treg功能,p300在过敏性喘中起着保护作用.
- p300增强了Treg介导的Th2驱动的气道炎症的抑制,部分通过GBP5调节.
相关概念视频
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
T Cell Activation and Clonal Selection
14.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.7K


